深圳康泰生物制品股份有限公司 KANGTAI BIOLOGICAL
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Cooperation Agreement Concluded between BioKangtai and Biotis 2023-04-07 10:41
Licensing and Agency Agreement Signed between Beijing Minhai (Biokangtai) and Phil. Pharmawealth, Inc. 2022-08-31 17:05
BIOKANGTAI Signs a Cooperation Agreement with the Largest Importer of Parenteral Products in Philippines 2022-03-21 22:22
Kangtai Adenovirus Vector COVID-19 Vaccine (KCONECAVAC) Exported for the First Time 2021-11-19 18:52
BioKangtai's adenovirus vector COVID-19 vaccine obtained EUA in Indonesia 2021-11-03 19:02
Biokangtai: Recombinant COVID-19 Vaccine(Adenovirus Vector) licensed for manufacturing, which actively promotes vaccine export and improves vaccine accessibility 2021-09-09 11:40
BIOKANGTAI COVID-19 Vaccine Approved for Phase III Clinical Trial in the Philippines 2021-08-02 15:25
Phase III Clinical Trial of BIOKANGTAI COVID-19 Vaccine Initiated in Malaysia 2021-06-22 22:32
1